register

Medical and Science

Private oncologists welcome subsidised telehealth for vulnerable patients

Health Industry Hub | March 18, 2020 |

The nation’s peak body of cancer doctors has applauded the Morrison Government for its swift and unprecedented move to offer bulkbilled telehealth appointments for certain groups of vulnerable Australians.

The Private Cancer Physicians of Australia (PCPA) said the pace in which the Government has moved to apply Medicare Benefits Schedule (MBS) items to telehealth GP and specialist appointments for patients, most at risk of the COVID-19 virus (or those self-isolating), was unprecedented.

“Like any patient with an underlying chronic health issues, cancer patients are particularly vulnerable during this pandemic,” said the President of the PCPA, Dr Christopher Steer. 

“Our patients are regular attendees at their GP clinics and out-patient clinics, which are now being frequented with those who have the COVID-19 virus.

“If cancer patients, many of whom will have a compromised immunity, can be provided with medical advice and support, over the phone or via a videoconference, rather than sitting in a doctors’ waiting room, then that is a significantly safer option for them,” Dr Steer said.

Register FREE and join 20,000+ industry professionals who receive the latest industry news, innovations and insights from Health Industry Hub; the ONLY one-stop-hub connecting Australia’s Pharma, MedTech and Biotech industry professionals and its key stakeholders.

The measure MBS Telehealth, was announced by the Morrison Government last week.

This is a temporary six-month measure. Should the Australian Health Protection Principal Committee (AHPPC) recommend an extension, it will be considered by the Government.

“Being diagnosed with cancer and having treatment is stressful as it is,” said Dr Steer. “Knowing you can now access a bulk billed appointment with your doctor, from the safety of your own home, is a very welcomed development and one we hope may continue past this pandemic.”

HCP engagement in COVID-19 times – Keep your people safe and maximise HCP reach and engagement digitally. Learn more about how we can help your team – solutions developed by industry for industry.


Human Resources

Merck puts the 'family' in workplace as fertility survey exposes gaps

Merck puts the ‘family’ in workplace as fertility survey exposes gaps

Health Industry Hub | September 16, 2026 |

Merck has announced the results of its Fertility Futures Survey of 1,500 Australians aged 18 to 35, revealing significant gaps […]

More


News - MedTech & Diagnostics

Australia has a new genomics framework. But will patients see the difference?

Australia has a new genomics framework. But will patients see the difference?

Health Industry Hub | September 16, 2026 |

The government has released the National Health Genomics Policy Framework and Implementation Plan 2026–2030, jointly developed by the federal and […]

More


News - Pharmaceuticals

PCFA condemns funding axe and demands Prime Minister intervene

PCFA condemns funding axe and demands Prime Minister intervene

Health Industry Hub | September 16, 2026 |

The Prostate Cancer Foundation of Australia (PCFA) has condemned the Albanese Government’s decision to end funding for its national Prostate […]

More


News - Pharmaceuticals

Sanofi’s clinical-trial push hits a GP reality check

Sanofi’s clinical-trial push hits a GP reality check

Health Industry Hub | September 16, 2026 |

New research from Sanofi presented at the Australian Public Health Conference this week points to an addressable opportunity to increase […]

More


This content is copyright protected. Please subscribe to gain access.